The mechanisms and reversal strategies of tumor radioresistance in esophageal squamous cell carcinoma Hongfang ZhangJingxing SiShenglin Ma Review – Cancer Research 09 March 2021 Pages: 1275 - 1286
The tumor suppressor role of salvador family WW domain-containing protein 1 (SAV1): one of the key pieces of the tumor puzzle Ísis Salviano Soares de AmorimMariana Moreno de Sousa RodriguesAndre Luiz Mencalha Review – Cancer Research 12 February 2021 Pages: 1287 - 1297
Bi-direction effects between microbiome and MiRNAs in carcinogenesis Qinglin WangHanlin DingQixing Mao Review – Cancer Research 25 March 2021 Pages: 1299 - 1305
Metastasis-directed stereotactic body radiation therapy in the management of oligometastatic head and neck cancer Ciro FranzeseM. BadalamentiM. Scorsetti Original Article – Cancer Research 20 January 2021 Pages: 1307 - 1313
HER2 copy number as predictor of disease-free survival in HER2-positive resectable gastric adenocarcinoma Zimin LiuMingpeng ShiLu Zhang Original Article – Cancer Research Open access 04 February 2021 Pages: 1315 - 1324
Socioeconomic disparities in head and neck cancer survival in Germany: a causal mediation analysis using population-based cancer registry data Ahmed BedirSemaw Ferede AberaDaniel Medenwald Original Article – Cancer Research Open access 11 February 2021 Pages: 1325 - 1334
The potential of somatostatin receptor 2 as a novel therapeutic target in salivary gland malignant tumors Amichay MeirovitzKarny Shouchane-BlumJeffrey Weinberger Original Article – Cancer Research 17 February 2021 Pages: 1335 - 1340
Clinicopathological impacts of DNA methylation alterations on pancreatic ductal adenocarcinoma: prediction of early recurrence based on genome-wide DNA methylation profiling Yutaka EndoMao FujimotoEri Arai Original Article – Cancer Research Open access 26 February 2021 Pages: 1341 - 1354
Using ultrasound-targeted microbubble destruction to enhance radiotherapy of glioblastoma Chanjuan PengYong WuChen Yang Original Article – Cancer Research Open access 06 February 2021 Pages: 1355 - 1363
Personalized oncology and BRAFK601N melanoma: model development, drug discovery, and clinical correlation Brian A. KellerBrian J. LaightJohn C. Bell Original Article – Cancer Research 08 February 2021 Pages: 1365 - 1378
Mycoplasma hyorhinis infection promotes tyrosine kinase inhibitor (TKI) resistance in lung adenocarcinoma patients Yueyu DaiFangyuan ZhongWeiguo Hu Original Article – Cancer Research 06 February 2021 Pages: 1379 - 1388
Exploring the role of BAFF as biomarker in the detection of uveal melanoma metastases Zenan LinDaniela Süsskind Original Article – Cancer Research 04 March 2021 Pages: 1389 - 1405
Are there sex differences among colorectal cancer patients in treatment and survival? A Swiss cohort study Manuela LimamKatarina Luise MatthesSabine Rohrmann Original Article – Cancer Research Open access 04 March 2021 Pages: 1407 - 1419
Sphingosine-kinase-1 expression is associated with improved overall survival in high-grade serous ovarian cancer L. C. HankerA. El-BalatF. Hoellen Original Article – Cancer Research Open access 03 March 2021 Pages: 1421 - 1430
Clinical application of circulating tumor DNA in breast cancer Jeffrey Chun Hin ChanJames Chung Hang ChowWilliam C. Cho Review – Clinical Oncology 24 March 2021 Pages: 1431 - 1442
Diet-related interventions for cancer-associated cachexia Alan J. KimDavid S. HongGoldy C. George Review – Clinical Oncology 15 March 2021 Pages: 1443 - 1450
Association of PD-L1 and IDO1 expression with JAK–STAT pathway activation in soft-tissue leiomyosarcoma Takeshi IwasakiKenichi KohashiYoshinao Oda Original Article – Clinical Oncology 20 September 2020 Pages: 1451 - 1463
Correction to: Association of PD-L1 and IDO1 expression with JAK–STAT pathway activation in soft-tissue leiomyosarcoma Takeshi IwasakiKenichi KohashiYoshinao Oda Correction 24 November 2020 Pages: 1465 - 1467
Impact of stopping therapy during the SARS-CoV-2 pandemic in persons with lymphoma Shenmiao YangDong DongXiaojun Huang Original Article – Clinical Oncology 19 October 2020 Pages: 1469 - 1479
Interferon alpha for essential thrombocythemia during 34 high-risk pregnancies: outcome and safety Lukas SchrickelFlorian H. HeidelFor the German Study Group MPN, GSG-MPN Original Article – Clinical Oncology 02 November 2020 Pages: 1481 - 1491
The previously common post-kidney transplant Kaposi sarcoma has become non-existent for a decade: an Egyptian experience Ahmed Farouk DoniaMohammed Ashraf FoudaBedeir Ali-El-Dein Original Article – Clinical Oncology 01 November 2020 Pages: 1493 - 1498
The forkhead box M1 (FOXM1) expression and antitumor effect of FOXM1 inhibition in malignant rhabdoid tumor Yuichi ShibuiKenichi KohashiYoshinao Oda Original Article – Clinical Oncology 21 November 2020 Pages: 1499 - 1518
Feasibility of limited resection for peripheral small-sized non-small cell lung cancer: a retrospective single-center-based study Masato AragakiYasuhiro HidaSatoru Wakasa Original Article – Clinical Oncology 05 November 2020 Pages: 1519 - 1527
Nab-paclitaxel plus S-1 versus nab-paclitaxel plus gemcitabine as first-line chemotherapy in patients with advanced pancreatic ductal adenocarcinoma: a randomized study Yuan ZongJiajia YuanJun Zhou Original Article – Clinical Oncology 15 November 2020 Pages: 1529 - 1536
Analysis of failed therapy evaluations in radioembolization of primary and secondary liver cancers Max MasthoffPhilipp SchindlerMoritz Wildgruber Original Article – Clinical Oncology Open access 06 November 2020 Pages: 1537 - 1545
Clinicopathological and molecular characteristics associated with PD-L1 expression in non-small cell lung cancer: a large-scale, multi-center, real-world study in China Qiang ZhengYan HuangYuan Li Original Article – Clinical Oncology 16 November 2020 Pages: 1547 - 1556
Overexpressed CA12 has prognostic value in pancreatic cancer and promotes tumor cell apoptosis via NF-κB signaling Yan DuZechang XinJie Yao Original Article – Clinical Oncology 02 January 2021 Pages: 1557 - 1564
Comment on article by Christina Puhr Hannah et al.: Clinical characteristics and comparison of the outcome in young versus older patients with upper gastrointestinal carcinoma Xiao YangChang-sheng Xie Letter to the Editor 27 February 2021 Pages: 1565 - 1565
Clinical characteristics and comparison of the outcome in young versus older patients with upper gastrointestinal carcinoma Hannah Christina PuhrAyseguel Ilhan-Mutlu Letter to the Editor 27 February 2021 Pages: 1567 - 1568